(IHF) iShares U.S. Healthcare - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US4642888287 • Health
IHF: Hospitals, Health Insurers, Pharmacy Benefit Managers, Medical Suppliers
The index measures the performance of the healthcare providers sector of the U.S. equity market, as defined by SPDJI. The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified. ‣ Company URL: http://www.ishares.com ‣ Domicile: United States
Additional Sources for IHF ETF
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
IHF ETF Overview
| Market Cap in USD | 656m |
| Category | Health |
| TER | 0.40% |
| IPO / Inception | 2006-05-01 |
IHF ETF Ratings
| Growth 5y | 35.0% |
| Fundamental | - |
| Dividend | 42.6% |
| Rel. Strength Industry | -105 |
| Analysts | - |
| Fair Price Momentum | 45.86 USD |
| Fair Price DCF | - |
IHF Dividends
| Dividend Yield 12m | 0.80% |
| Yield on Cost 5y | 1.08% |
| Annual Growth 5y | 10.45% |
| Payout Consistency | 60.9% |
IHF Growth Ratios
| Growth Correlation 3m | -67.2% |
| Growth Correlation 12m | 6% |
| Growth Correlation 5y | 57.4% |
| CAGR 5y | 6.05% |
| CAGR/Mean DD 5y | 0.79 |
| Sharpe Ratio 12m | -0.28 |
| Alpha | -26.90 |
| Beta | 0.95 |
| Volatility | 19.51% |
| Current Volume | 104.4k |
| Average Volume 20d | 106k |
What is the price of IHF stocks?
As of January 23, 2025, the stock is trading at USD 51.06 with a total of 104,400 shares traded.
Over the past week, the price has changed by +1.07%, over one month by +5.45%, over three months by -3.91% and over the past year by -1.31%.
As of January 23, 2025, the stock is trading at USD 51.06 with a total of 104,400 shares traded.
Over the past week, the price has changed by +1.07%, over one month by +5.45%, over three months by -3.91% and over the past year by -1.31%.
Is iShares U.S. Healthcare a good stock to buy?
Partly, yes. Based on ValueRay Analyses, iShares U.S. Healthcare (NYSE ARCA:IHF) is currently (January 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 35.01 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IHF as of January 2025 is 45.86. This means that IHF is currently overvalued and has a potential downside of -10.18%.
Partly, yes. Based on ValueRay Analyses, iShares U.S. Healthcare (NYSE ARCA:IHF) is currently (January 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 35.01 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IHF as of January 2025 is 45.86. This means that IHF is currently overvalued and has a potential downside of -10.18%.
Is IHF a buy, sell or hold?
iShares U.S. Healthcare has no consensus analysts rating.
iShares U.S. Healthcare has no consensus analysts rating.
What are the forecast for IHF stock price target?
According to ValueRays Forecast Model, IHF iShares U.S. Healthcare will be worth about 50.9 in January 2026. The stock is currently trading at 51.06. This means that the stock has a potential downside of -0.29%.
According to ValueRays Forecast Model, IHF iShares U.S. Healthcare will be worth about 50.9 in January 2026. The stock is currently trading at 51.06. This means that the stock has a potential downside of -0.29%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 50.9 | -0.3% |